Efficacy and Safety of Cefixime–Ofloxacin Combination in Typhoid Fever

Select Content Type
Resources
Authored By
Shalina MedSpace
Authored On
Interests
Cardiology
Dermatology
Emergency Medicine
Endocrinology
ENT
Gastroenterology
Hematology
Immunology Allergy & Inflammation
Infectious Disease & Vaccines
Internal/Family Medicine
Neurology
Obstetrics & Gynecology
Oncology
Ophthalmology
Orthopedic
Pain & Anesthesiology
Pediatric Medicine
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology & Nephrology
Speciality
Cardiology
Dentistry
Dermatology
Emergency Medicine
Endocrinology
ENT
Gastroenterology
Geriatrics
Hematology
Immunology Allergy & Inflammation
Infectious Disease & Vaccines
Internal/Family Medicine
Medical Genetics
Neurology
Obstetrics & Gynecology
Oncology
Ophthalmology
Orthopedic
Pain & Anesthesiology
Pathology
Pediatric Medicine
Pharmacology
Psychiatry
Public Health
Pulmonology
Radiology
Rheumatology
Surgery
Urology & Nephrology
Thumbnail Image
efficacy & safety_thumbnail
Detail Image
efficacy & safety_mobile
Book Detail
Actions
Download in App
Countries of release
India
Nigeria
UAE
IS_Ebsco
false
Description

A post-marketing surveillance study evaluated the efficacy and tolerability of a fixed-dose combination of cefixime and ofloxacin in 30 patients aged 18–72 years with typhoid fever. Treatment with Cefixime 200 mg + Ofloxacin 200 mg resulted in a significant reduction in body temperature. Nocturnal awakening due to fever markedly decreased after the third day of treatment. The study concluded that this combination offered effective, safe, and well-tolerated therapy for typhoid fever.

Published Date